Hanson & Doremus Investment Management Abb Vie Inc. Transaction History
Hanson & Doremus Investment Management
- $637 Million
- Q4 2024
A detailed history of Hanson & Doremus Investment Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 8,855 shares of ABBV stock, worth $1.5 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
8,855
Previous 7,319
20.99%
Holding current value
$1.5 Million
Previous $1.45 Million
8.86%
% of portfolio
0.25%
Previous 0.23%
Shares
28 transactions
Others Institutions Holding ABBV
# of Institutions
3,863Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$29 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.4 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$8.85 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.55 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $299B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...